vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and TECOGEN INC. (TGEN). Click either name above to swap in a different company.

CRYO CELL INTERNATIONAL INC is the larger business by last-quarter revenue ($7.8M vs $5.3M, roughly 1.5× TECOGEN INC.). CRYO CELL INTERNATIONAL INC runs the higher net margin — -48.7% vs -75.1%, a 26.4% gap on every dollar of revenue. On growth, CRYO CELL INTERNATIONAL INC posted the faster year-over-year revenue change (-2.3% vs -12.5%). CRYO CELL INTERNATIONAL INC produced more free cash flow last quarter ($1.2M vs $-2.6M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -7.3%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

CCEL vs TGEN — Head-to-Head

Bigger by revenue
CCEL
CCEL
1.5× larger
CCEL
$7.8M
$5.3M
TGEN
Growing faster (revenue YoY)
CCEL
CCEL
+10.2% gap
CCEL
-2.3%
-12.5%
TGEN
Higher net margin
CCEL
CCEL
26.4% more per $
CCEL
-48.7%
-75.1%
TGEN
More free cash flow
CCEL
CCEL
$3.8M more FCF
CCEL
$1.2M
$-2.6M
TGEN
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-7.3%
TGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCEL
CCEL
TGEN
TGEN
Revenue
$7.8M
$5.3M
Net Profit
$-3.8M
$-4.0M
Gross Margin
77.9%
36.8%
Operating Margin
-50.6%
-77.8%
Net Margin
-48.7%
-75.1%
Revenue YoY
-2.3%
-12.5%
Net Profit YoY
-105.1%
-236.7%
EPS (diluted)
$-0.46
$-0.14

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
TGEN
TGEN
Q4 25
$7.8M
$5.3M
Q3 25
$7.8M
$7.2M
Q2 25
$7.9M
$7.3M
Q1 25
$8.0M
$7.3M
Q4 24
$8.0M
$6.1M
Q3 24
$8.1M
$5.6M
Q2 24
$8.0M
$4.7M
Q1 24
$7.9M
$6.2M
Net Profit
CCEL
CCEL
TGEN
TGEN
Q4 25
$-3.8M
$-4.0M
Q3 25
$749.4K
$-2.1M
Q2 25
$355.8K
$-1.5M
Q1 25
$282.9K
$-659.9K
Q4 24
$-1.9M
$-1.2M
Q3 24
$1.1M
$-930.4K
Q2 24
$655.8K
$-1.5M
Q1 24
$556.2K
$-1.1M
Gross Margin
CCEL
CCEL
TGEN
TGEN
Q4 25
77.9%
36.8%
Q3 25
77.0%
30.4%
Q2 25
76.6%
33.8%
Q1 25
75.1%
44.3%
Q4 24
78.4%
45.0%
Q3 24
73.6%
44.1%
Q2 24
74.8%
44.0%
Q1 24
73.7%
41.6%
Operating Margin
CCEL
CCEL
TGEN
TGEN
Q4 25
-50.6%
-77.8%
Q3 25
24.3%
-29.2%
Q2 25
18.8%
-19.4%
Q1 25
13.3%
-8.2%
Q4 24
-1.5%
-18.7%
Q3 24
17.2%
-15.5%
Q2 24
17.3%
-31.2%
Q1 24
10.5%
-17.0%
Net Margin
CCEL
CCEL
TGEN
TGEN
Q4 25
-48.7%
-75.1%
Q3 25
9.6%
-29.7%
Q2 25
4.5%
-20.1%
Q1 25
3.5%
-9.1%
Q4 24
-23.2%
-19.5%
Q3 24
13.0%
-16.5%
Q2 24
8.2%
-32.5%
Q1 24
7.1%
-17.9%
EPS (diluted)
CCEL
CCEL
TGEN
TGEN
Q4 25
$-0.46
$-0.14
Q3 25
$0.09
$-0.07
Q2 25
$0.04
$-0.06
Q1 25
$0.03
$-0.03
Q4 24
$-0.23
$-0.05
Q3 24
$0.13
$-0.04
Q2 24
$0.08
$-0.06
Q1 24
$0.07
$-0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
TGEN
TGEN
Cash + ST InvestmentsLiquidity on hand
$3.3M
$12.4M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$21.6M
Total Assets
$61.7M
$37.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
TGEN
TGEN
Q4 25
$3.3M
$12.4M
Q3 25
$3.2M
$15.3M
Q2 25
$4.4M
$1.6M
Q1 25
$3.5M
$4.1M
Q4 24
$3.5M
$5.4M
Q3 24
$2.1M
$1.3M
Q2 24
$1.5M
$841.9K
Q1 24
$979.6K
$1.5M
Total Debt
CCEL
CCEL
TGEN
TGEN
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
TGEN
TGEN
Q4 25
$-18.6M
$21.6M
Q3 25
$-14.8M
$25.5M
Q2 25
$-15.6M
$9.1M
Q1 25
$-14.7M
$9.6M
Q4 24
$-13.2M
$10.2M
Q3 24
$-9.6M
$11.3M
Q2 24
$-10.7M
$12.2M
Q1 24
$-10.3M
$13.7M
Total Assets
CCEL
CCEL
TGEN
TGEN
Q4 25
$61.7M
$37.0M
Q3 25
$63.2M
$41.5M
Q2 25
$64.4M
$28.4M
Q1 25
$64.4M
$29.7M
Q4 24
$64.7M
$31.1M
Q3 24
$62.9M
$27.5M
Q2 24
$62.6M
$27.2M
Q1 24
$61.7M
$28.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
TGEN
TGEN
Operating Cash FlowLast quarter
$1.3M
$-2.6M
Free Cash FlowOCF − Capex
$1.2M
$-2.6M
FCF MarginFCF / Revenue
15.5%
-49.3%
Capex IntensityCapex / Revenue
0.9%
0.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$-10.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
TGEN
TGEN
Q4 25
$1.3M
$-2.6M
Q3 25
$2.5M
$-3.6M
Q2 25
$707.0K
$-2.6M
Q1 25
$954.1K
$-1.2M
Q4 24
$2.2M
$4.2M
Q3 24
$2.4M
$-207.3K
Q2 24
$1.8M
$-157.9K
Q1 24
$-356.9K
$248.2K
Free Cash Flow
CCEL
CCEL
TGEN
TGEN
Q4 25
$1.2M
$-2.6M
Q3 25
$2.5M
$-3.6M
Q2 25
$644.6K
$-2.7M
Q1 25
$892.0K
$-1.3M
Q4 24
$2.1M
$4.0M
Q3 24
$2.3M
$-489.6K
Q2 24
$21.5K
$-609.6K
Q1 24
$-814.6K
$143.3K
FCF Margin
CCEL
CCEL
TGEN
TGEN
Q4 25
15.5%
-49.3%
Q3 25
31.9%
-50.6%
Q2 25
8.1%
-37.7%
Q1 25
11.2%
-17.9%
Q4 24
26.8%
66.6%
Q3 24
27.9%
-8.7%
Q2 24
0.3%
-12.9%
Q1 24
-10.4%
2.3%
Capex Intensity
CCEL
CCEL
TGEN
TGEN
Q4 25
0.9%
0.9%
Q3 25
0.5%
1.0%
Q2 25
0.8%
2.0%
Q1 25
0.8%
1.8%
Q4 24
0.1%
2.1%
Q3 24
2.3%
5.0%
Q2 24
21.8%
9.6%
Q1 24
5.8%
1.7%
Cash Conversion
CCEL
CCEL
TGEN
TGEN
Q4 25
Q3 25
3.38×
Q2 25
1.99×
Q1 25
3.37×
Q4 24
Q3 24
2.32×
Q2 24
2.70×
Q1 24
-0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCEL
CCEL

Segment breakdown not available.

TGEN
TGEN

Installation Services$4.5M84%
Products Segment$460.5K9%
Other$394.7K7%

Related Comparisons